What It Is
Remote Patient Monitoring System for Pediatrics
Founded by CJ Swamy in 2016
Why Vive Invested
CJ’s passion for managing chronic conditions was evident from our first meeting. We could tell immediately that Kiddo would be his life’s work. Kiddo’s mission to help parents better manage their children’s conditions through technology, data, and insights fit our thesis on care moving outside the four walls of the clinic and our mission to fund improved access to care.
Why Kiddo Chose Vive
"I believe every founder should look for 3 qualities in an investor: deep industry knowledge, a supportive personality and a strong balance sheet. Vive checks all the boxes with aplomb. Cheryl is very knowledgeable about digital health models and loves visionary products. She and Alex are extremely supportive investors - the kind you can call at 10 pm in the night to solve a problem with. And the Clearlake name backing Vive is a huge plus - making Vive a credible investor that you definitely want on your cap table. That's why, although we had a few other interested investors, we knew very quickly that Cheryl and Alex at Vive would be the best investors for us and we are absolutely delighted to have Vive join us on the Kiddo journey".
At-home heart health management
Hello Heart
2014
Investors and Co-Investors
Maven Ventures, Khosla Ventures, IVP
Digital health solutions for women 40+
gennev
2016
Investors and Co-Investors
Maven Ventures, Rise of the Rest
An online space for Gen Z to increase belonging and resilience
Blue Fever
2017
Investors and Co-Investors
Halogen Ventures, Amazon Alexa Fund, Serena Ventures
Online counseling designed for teens
Daybreak Health
2018
Investors and Co-Investors
YC, Vinaj, FORM Life
Genome sequencing for tumors
Isabl
2019
Investors and Co-Investors
Two Sigma Ventures
SELECT PAST (NON-VIVE) INVESTMENTS
DIGITAL HEALTH
I first met Cheryl while raising my $2m seed round. Cheryl helped me structure a creative arrangement for the round, and became an Angel Investor among the founders of Skype, YouTube, Cloudera, Salesforce and Tinder. I chose to work with Cheryl because she gave me the kind of hands-on counsel that my other investors couldn’t. FOSSA has since raised over $35m and I consider Cheryl a trusted confidant. Through the years I’ve met many founders that know Cheryl, and I find that my experience with her is consistent across every founder that has chosen to work with her. I think it’s an advantage to any founder who wants to navigate SV to have Cheryl in your corner.
I first met Cheryl while raising my $2m seed round. Cheryl helped me structure a creative arrangement for the round, and became an Angel Investor among the founders of Skype, YouTube, Cloudera, Salesforce and Tinder. I chose to work with Cheryl because she gave me the kind of hands-on counsel that my other investors couldn’t. FOSSA has since raised over $35m and I consider Cheryl a trusted confidant. Through the years I’ve met many founders that know Cheryl, and I find that my experience with her is consistent across every founder that has chosen to work with her. I think it’s an advantage to any founder who wants to navigate SV to have Cheryl in your corner.
I first met Cheryl while raising my $2m seed round. Cheryl helped me structure a creative arrangement for the round, and became an Angel Investor among the founders of Skype, YouTube, Cloudera, Salesforce and Tinder. I chose to work with Cheryl because she gave me the kind of hands-on counsel that my other investors couldn’t. FOSSA has since raised over $35m and I consider Cheryl a trusted confidant. Through the years I’ve met many founders that know Cheryl, and I find that my experience with her is consistent across every founder that has chosen to work with her. I think it’s an advantage to any founder who wants to navigate SV to have Cheryl in your corner.
Kevin Wang
Founder & CEO of FOSSA
I first met Cheryl while raising my $2m seed round. Cheryl helped me structure a creative arrangement for the round, and became an Angel Investor among the founders of Skype, YouTube, Cloudera, Salesforce and Tinder. I chose to work with Cheryl because she gave me the kind of hands-on counsel that my other investors couldn’t. FOSSA has since raised over $35m and I consider Cheryl a trusted confidant. Through the years I’ve met many founders that know Cheryl, and I find that my experience with her is consistent across every founder that has chosen to work with her. I think it’s an advantage to any founder who wants to navigate SV to have Cheryl in your corner.
I first met Cheryl while raising my $2m seed round. Cheryl helped me structure a creative arrangement for the round, and became an Angel Investor among the founders of Skype, YouTube, Cloudera, Salesforce and Tinder. I chose to work with Cheryl because she gave me the kind of hands-on counsel that my other investors couldn’t. FOSSA has since raised over $35m and I consider Cheryl a trusted confidant. Through the years I’ve met many founders that know Cheryl, and I find that my experience with her is consistent across every founder that has chosen to work with her. I think it’s an advantage to any founder who wants to navigate SV to have Cheryl in your corner.
We had 2 terms sheets on the table and I decided to take Cheryl’s offer even though the valuation was lower. I wanted a strong partner that deeply understands the digital health market and can help me navigate the unique challenges of this market. Today with 20x revenue after the investment I can say that I couldn’t have asked for a better partner. Cheryl asks tough questions, provides perspective, gives founders room to breathe and think, and is incredibly supportive to CEO-founders. She is not just an investor to me today, she is a trusted confidant.
Maayan Cohen
Co-founder and CEO of Hello Heart
I first met Cheryl while raising my $2m seed round. Cheryl helped me structure a creative arrangement for the round, and became an Angel Investor among the founders of Skype, YouTube, Cloudera, Salesforce and Tinder. I chose to work with Cheryl because she gave me the kind of hands-on counsel that my other investors couldn’t. FOSSA has since raised over $35m and I consider Cheryl a trusted confidant. Through the years I’ve met many founders that know Cheryl, and I find that my experience with her is consistent across every founder that has chosen to work with her. I think it’s an advantage to any founder who wants to navigate SV to have Cheryl in your corner.
I first met Cheryl while raising my $2m seed round. Cheryl helped me structure a creative arrangement for the round, and became an Angel Investor among the founders of Skype, YouTube, Cloudera, Salesforce and Tinder. I chose to work with Cheryl because she gave me the kind of hands-on counsel that my other investors couldn’t. FOSSA has since raised over $35m and I consider Cheryl a trusted confidant. Through the years I’ve met many founders that know Cheryl, and I find that my experience with her is consistent across every founder that has chosen to work with her. I think it’s an advantage to any founder who wants to navigate SV to have Cheryl in your corner.
Cheryl is the kind of rare investment partner founders dream of. She is an experienced operator, endlessly creative, and understands the struggles of early stage companies, guiding founders and CEOs with compassion, enthusiasm, and invaluable deep market knowledge. Getting to know and working with Cheryl has been one of the highlights of my career and one of the best things that ever happened to our company.
Vanessa Didyk
CEO of ZeeMee
WHAT FOUNDERS SAY ABOUT US
What It Is
Prior Authorization Platform for Specialty Medications
Founded by Syam Palakurthy & Scott Zhang in 2018
Why Vive Invested
We were impressed with Syam's thoughtful approach towards building a prior authorization and benefits verification platform that facilitates specialty medication onboarding. The Samacare platform aligns the goals and needs of patients, providers and payers. The specialty medication market will only continue to grow as innovation in drugs are predominantly in biologics and infusion based medications. We are excited to partner with Syam and the whole Samacare team to improve access to critical medications.
Why SamaCare Chose Vive
"We chose Vive because we wanted investors who truly believe in SamaCare’s mission to create a world where patients get on therapy because of clinical considerations, and not due to administrative or financial considerations. Cheryl and her amazing team have an in-depth understanding of healthcare industry drivers, as well as an impressive network in the space. For us, it was vitally important to find an investor who knew the ins and outs of what it takes to make a healthcare tech business succeed, because the space operates like the funhouse-mirror version of most other industries. The Vive team’s deep expertise, network, passion, and the gravitas of the Clearlake name backing make Vive a perfect partner for SamaCare."